EQUITY (Details) - Warrants Member - $ / shares |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
Number Of Shares Outstanding, Beginning | 23,315 | 40,442 | 45,025 |
Number Of Shares Outstanding, Expired | 17,127 | 4,583 | |
Number Of Shares Outstanding, Ending | 23,315 | 23,315 | 40,442 |
Weighted Average Exercie Price, Beginning | $ 67.50 | $ 294.29 | $ 385.32 |
Weighted Average Exercise Price, Granted | 0 | 0 | 0 |
Weighted Average Exercise Price Exercised | 0 | 0 | 0 |
Weighted Average Exercise Price Expired | 0 | ||
Weighted Average Exercie Price, Ending | $ 67.50 | $ 67.50 | $ 294.29 |
Weighted Average Life (years), Beginning | 9 months 15 days | ||
Weighted Average Life (years), Ending | 6 months 14 days |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|